Innovent Biologics (1801.HK) Worth A Look

By HEFFX Australia on July 28, 2020   Asia, Headline News, Health, Investments, Shayne Heffernan, Shayne Heffernan, Stocks, Top Stories  

$1801.HK #Innovent #Biologics #HongKong #HSI #Stocks #Trading Innovent BiologicsTicker: 1801.HKPrice: HKD48.95 Business Summary Innovent Biologics, Inc. is a China-based biopharmaceutical company. The Company’s main products include PD-1 antibody; bevacizumab (Avastin) biosimilar, IBI-305; rituximab (MabThera/Rituxan) biosimilar, IBI-301; and adalimumab (Humira) biosimilar, IBI-303. Price Performance Relative Valuation Technical Indicators Overall, the bias in prices is: Upwards. The […]